GB201115537D0 - Assay - Google Patents

Assay

Info

Publication number
GB201115537D0
GB201115537D0 GB201115537A GB201115537A GB201115537D0 GB 201115537 D0 GB201115537 D0 GB 201115537D0 GB 201115537 A GB201115537 A GB 201115537A GB 201115537 A GB201115537 A GB 201115537A GB 201115537 D0 GB201115537 D0 GB 201115537D0
Authority
GB
United Kingdom
Prior art keywords
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB201115537A
Other versions
GB2499180A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcyomics Ltd
Original Assignee
Alcyomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcyomics Ltd filed Critical Alcyomics Ltd
Priority to GB201115537A priority Critical patent/GB2499180A/en
Publication of GB201115537D0 publication Critical patent/GB201115537D0/en
Publication of GB2499180A publication Critical patent/GB2499180A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5002—Partitioning blood components
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
GB201115537A 2011-09-08 2011-09-08 Method of identifying sensitizers or allergens using measurements of T-cell proliferation and/or IFN Gamma Withdrawn GB2499180A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB201115537A GB2499180A (en) 2011-09-08 2011-09-08 Method of identifying sensitizers or allergens using measurements of T-cell proliferation and/or IFN Gamma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201115537A GB2499180A (en) 2011-09-08 2011-09-08 Method of identifying sensitizers or allergens using measurements of T-cell proliferation and/or IFN Gamma

Publications (2)

Publication Number Publication Date
GB201115537D0 true GB201115537D0 (en) 2011-10-26
GB2499180A GB2499180A (en) 2013-08-14

Family

ID=44908265

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201115537A Withdrawn GB2499180A (en) 2011-09-08 2011-09-08 Method of identifying sensitizers or allergens using measurements of T-cell proliferation and/or IFN Gamma

Country Status (1)

Country Link
GB (1) GB2499180A (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1469721B1 (en) * 2000-10-02 2011-04-06 Danisco US Inc. Method of determining the immunogenicity of proteins producing an altered immunogenic response
US20080220450A1 (en) * 2004-04-26 2008-09-11 Danisco Us, Inc., Genencor Division Population Based Prediction Methods for Immune Response Determinations and Methods for Verifying Immunological Response Data

Also Published As

Publication number Publication date
GB2499180A (en) 2013-08-14

Similar Documents

Publication Publication Date Title
EP2536818A4 (en) Immobilised-bead immunomultiplex assay
AP2014007621A0 (en) 2-Thiopyrimidinones
PL2729809T3 (en) Assay
EP2791351A4 (en) Fibrinogen assay
GB201118293D0 (en) Electrochemical assay
GB201106615D0 (en) Assay
GB201118026D0 (en) Biosensor
GB201021711D0 (en) Assay
GB201004306D0 (en) Assay
GB201212528D0 (en) Assay
GB201119028D0 (en) Dengue assay
GB201002382D0 (en) Assay
GB201102659D0 (en) Assay
GB201121265D0 (en) Assay
GB201113101D0 (en) Assay
GB201121573D0 (en) Assay
GB201117309D0 (en) Assay
GB201115537D0 (en) Assay
GB201115091D0 (en) Assay
GB201114404D0 (en) Assay
GB201111698D0 (en) Assay
GB201111634D0 (en) Assay
GB201111608D0 (en) Assay
GB201110612D0 (en) Assay
GB201107431D0 (en) Assay

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)